Health & Wellness - 2019 Archives
December 5, 2019
The company that makes aducanumab for Alzheimer's disease says that the drug slows mental decline. Biogen Inc. revealed its new analyses of data from its phase 3[...]
February 20, 2019
February 19, 2019
February 19, 2019
February 18, 2019
February 18, 2019
February 18, 2019
February 18, 2019
February 16, 2019
February 15, 2019
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community